Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
Title:
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
Author:
Weber, Jeffrey S. Poretta, Tayla Stwalley, Brian D. Sakkal, Leon A. Du, Ella X. Wang, Travis Chen, Yan Wang, Yan Betts, Keith A. Shoushtari, Alexander N.